Gene therapy proven to work in treatment of Parkinson's disease
Scientists have proved for the first time that gene therapy is an effective treatment for Parkinson's disease, the progressive disorder of the nervous system which causes tremors, delayed movements and rigidity.
Patients who had a gene that controls the chemical responsible for co-ordinating movement put directly into their brains experienced significant improvement in their ability to control their hands, get up and walk.
It is the first time a randomised, double blind trial has demonstrated the effectiveness of the therapy in Parkinson's disease, which affects 120,000 people in the UK.
By replacing defective genes with properly functioning ones, gene therapy could, in theory, correct the basis of many diseases. Moreover, a single treatment should have lifelong effects, removing the need for daily treatment with drugs or regular check-ups.
Scientists said the latest advance demonstrated that the therapy could work for a range of neurological disorders. Professor Adrian Thrasher, president of the British Society of Gene Therapy, said: "It has proved extremely efficacious in blood disorders and in disorders of the retina. Using genes in the treatment of disease does have great potential."
American scientists conducted the trial on 45 patients in the US. Half had burr holes drilled into their skulls and a solution containing the gene, called GAD, and a harmless virus, AAV2, infused into an area of the brain called the subthalamic nucleus.
The AAV2 virus was used to carry the gene into the cells by infecting them. The virus is thought to be safe – more than 80 per cent of the population have been exposed to it and it is not known to cause any disease – but its long-term effects in the brain are not known.
The remaining half of the patients were the control group. They had sham surgery – the burr holes were drilled halfway through their skulls and were washed with catheters carrying saline solution in the same way as the treatment group.
The brain has no sensation and although all the patients in both groups were awake during the procedure, they were unable to tell whether they had received the genuine infusion or the sham version.
The results showed patients who received the gene therapy had twice the improvement in motor control compared with the sham surgery group after six months – an average gain of 23.1 per cent on the Parkinson's rating scale against 12.7 per cent.
Culinary experts in The Netherlands thought it was 'fresh' and 'tasty'
Of all the computers Apple has ever made there’s only one that Steve Jobs had to sell his car to finance
Marvel has released first teaser trailer week early after it leaked online
Life & Style blogs
Nokia no more: Microsoft drops once-ubiquitous mobile name – in favour of its Lumia brand
Fake goats’ cheese found in supermarkets
Alternatives to cow’s milk can cause Vitamin D deficiency
Handy hacks that make life easier: New book reveals how to rid your inbox of spam, protect your passwords and amplify your iPhone
St Bees in Cumbria is named the best place to raise a family in the UK
- 1 Nokia no more: Microsoft drops once-ubiquitous mobile name – in favour of its Lumia brand
- 2 Renee Zellweger on plastic surgery: 'I'm living a fulfilling life and I'm thrilled that perhaps it shows'
- 3 Banksy not arrested: Internet duped by fake report claiming artist's identity revealed
- 4 Australian café owner sparks debate after saying 'No' to having unruly children on premises
- 5 Paralysed man Darek Fidyka walks again after treatment by British doctors on brink of 'cure' for paralysis
£350 - £360 per day: Ashdown Group: SQL Developer with T-SQL, Watford, Hertfor...
£65000 - £80000 per annum: Ashdown Group: Business Intelligence Consultant - C...
£70 - £85 per day: Randstad Education Group: SEN Teaching Assistants needed in...
£21500 - £35000 per annum: Randstad Education Cambridge: Randstad Education ar...